Results 71 to 80 of about 16,198,215 (212)

The impact of stigma on people with opioid use disorder, opioid treatment, and policy.

open access: yes, 2022
Illicit drug use disorders are the most stigmatised health conditions worldwide, and stigma acts as a meaningful barrier to treatment entry and treatment provision.
Lubman, Dan I   +4 more
core   +1 more source

Pharmacy stakeholder reports on ethical and logistical considerations in anti-opioid vaccine development

open access: yesBMC Medical Ethics, 2021
Background As opioid use disorder (OUD) incidence and its associated deaths continue to persist at elevated rates, the development of novel treatment modalities is warranted.
Vincent Wartenweiler   +3 more
doaj   +1 more source

Neuropsychiatric Outcomes Associated With GLP‐1 Receptor Agonist Use in Medicare Beneficiaries With Type 2 Diabetes: Variation by Treatment Pattern and Obesity Status

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Glucagon‐like peptide‐1 (GLP‐1) receptors are expressed in brain regions governing mood, reward and stress, yet the neuropsychiatric effects of GLP‐1 receptor agonist (GLP‐1 RA) therapy remain poorly characterized. We estimated associations between GLP‐1 RA use and neuropsychiatric disorders and variation by obesity status and treatment ...
Seo Hyon Baik   +4 more
wiley   +1 more source

Pharmacy-based preventive services for opioid use disorder: a survey of U.S. pharmacists

open access: yesAddiction Science & Clinical Practice
Background Pharmacists play a key role in combating the opioid-related overdose epidemic in the United States (US), but little is known about their experience and willingness to deliver preventive services for opioid use disorder (OUD).
Li-Tzy Wu   +8 more
doaj   +1 more source

Behind the Curtain of Care. Nurses' Experiences Providing Care to Consumers With Alcohol and Other Drug Issues: A Qualitative Scoping Review

open access: yesJournal of Clinical Nursing, EarlyView.
ABSTRACT Aim To scope and synthesise qualitative literature relating to nurses' experiences of providing care to consumers with alcohol and other drug issues and explore how meaning is constructed in practice. Design Scoping review. Methods A scoping review was conducted following Arksey and O'Malley's framework.
Kylie Kearns   +2 more
wiley   +1 more source

Family member opioid prescriptions and opioid use disorder

open access: yes, 2019
It is recognized that family members are a major source of diverted opioids. Yet it is not known how family member opioid prescriptions predict the development of an opioid use disorder (OUD).We conducted an observational study using commercial health ...
Mazer-Amirshahi, Maryann   +6 more
core   +1 more source

Case report: acute care management of severe opioid withdrawal with IV fentanyl

open access: yesAddiction Science & Clinical Practice, 2022
Background An increasing number of individuals who use drugs in North America are preferentially consuming fentanyl over other opioids. This has significant consequences on the treatment and management of opioid use disorder (OUD) and its concurrent ...
Pouya Azar   +6 more
doaj   +1 more source

Exploring metacognitive function in patients with opioid use disorder: A pilot study

open access: yesPsychology and Psychotherapy: Theory, Research and Practice, EarlyView.
Abstract Objectives Despite recognised cognitive deficits related to substance use, as well as high mortality and treatment attrition rates, metacognition has never been studied in patients with opioid use disorder (OUD) undergoing opioid maintenance treatment (OMT).
John Hanson Högberg   +3 more
wiley   +1 more source

Success Among Incarcerated Mothers Seeking Treatment for Opioid Use Disorder [PDF]

open access: yes, 2022
Opioid use disorder (OUD) is a type of substance use disorder characterized by repeated use of opioid drugs. These drugs are known to be rapidly addictive with severe withdrawal symptoms, making death due to overdose a rising concern.
Desai, Brinna
core  

Genetic Liability to Opioid Use Disorder and Dementia‐Related Biological Pathways: A Mendelian Randomisation Study

open access: yesInternational Journal of Geriatric Psychiatry, Volume 41, Issue 11, November 2026.
ABSTRACT Objectives Opioid use disorder (OUD) is increasingly recognised as a risk factor for cognitive impairment and dementia, but the biological mechanisms underlying this association remain unclear. We aimed to investigate the involvement of established neurodegenerative, vascular, or inflammatory pathways.
Sara Javidnia   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy